ghk-cu injectable half-life Facial Serum An FDA panel is reviewing

It may prevent the binding of the FOXO4 protein with p53, allowing p53 to bind with DNA and trigger apoptosis in senescent cells

The pathophysiology of IC/BPS is poorly understood, and theories include chronic inflammation, autoimmune dysregulation, bacterial cystitis, urothelial dysfunction, deficiency of the glycosaminoglycan (GAG) barrier and urine cytotoxicity

Personalized peptide protocols with optimal reconstitution schedules: SeekPeptides creates custom protocols showing exactly when to reconstitute each peptide based on your dosing frequency

According to Gruchlik et al, GHK-Cu decreases TNF-alpha-dependent IL-6 secretion in fibroblasts, and is preferable for use on the skin to corticosteroids or non-steroidal anti-inflammatory drugs, which have greater side effects [9]